By recreating the complexity of human neuromuscular systems using advanced 2D and 3D organoid models, we are accelerating the development of therapies for Charcot-Marie-Tooth disease.
Our innovative service drives the discovery of key compounds and unlocks new possibilities in neurological and myological research.
